Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Combinatorial effects of microRNA to suppress the myc oncogenic pathway (mRNA data)

ABSTRACT: microRNA importance in the myc pathway in Burkitt lymphoma. Gene expression data of Burkitt lymphoma samples and non-tumoral controls. 6 Burkitt lymphomas were compared with 16 non-tumoral controls. Universal Human Reference RNA was used as the reference sample. Significantly deregulated miRNAs were computed using the Significant Analysis of Microarray (SAM) analysis from the TM4 pathway and the limma package.

ORGANISM(S): Homo sapiens

SUBMITTER: Lorena Di Lisio

PROVIDER: E-GEOD-29492 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Combinatorial effects of microRNA to suppress the myc oncogenic pathway (miRNA data)

Project description:microRNA importance in the myc pathway in Burkitt lymphoma. MicroRNA data from the Agilent human miRNA platform. 12 Burkitt lymphomas were compared with 14 non-tumoral controls (lymph nodes, tonsils and CD19+CD10+ sorted cells). Significantly deregulated miRNAs were computed using the Significant Analysis of Microarray (SAM) analysis from the TM4 pathway and the limma package.

2012-04-08 | E-GEOD-29491 | biostudies-arrayexpress

Combinatorial effects of microRNA to suppress the myc oncogenic pathway

Project description:Many mammalian transcripts contain target sites for multiple miRNAs, although it is not clear to what extent miRNAs may coordinately regulate single genes. We have mapped the interactions between down-regulated miRNAs and overexpressed target protein-coding genes in murine and human lymphomas. Myc, one of the hallmark oncogenes in these lymphomas, stands out as the up-regulated gene with the highest number of genetic interactions with down-regulated miRNAs in mouse lymphomas. The regulation of Myc by several of these miRNAs is confirmed by cellular and reporter assays. The same approach identifies MYC and multiple Myc targets as a preferential target of down-regulated miRNAs in human Burkitt lymphoma, a pathology characterized by translocated MYC oncogenes. These results indicate that several miRNAs must be coordinately down-regulated to enhance critical oncogenes, such as Myc. Some of these Myc-targeting miRNAs are repressed by Myc, suggesting that these tumors are a consequence of the unbalanced activity of Myc versus miRNAs. This SuperSeries is composed of the following subset Series: GSE29491: Combinatorial effects of microRNA to suppress the myc oncogenic pathway (miRNA data) GSE29492: Combinatorial effects of microRNA to suppress the myc oncogenic pathway (mRNA data)

2012-03-29 | E-GEOD-23026 | biostudies-arrayexpress

Combinatorial effects of microRNA to suppress the myc oncogenic pathway (mRNA data)

Project description:microRNA importance in the myc pathway in Burkitt lymphoma.

2012-04-09 | GSE29492 | GEO

Combinatorial effects of microRNA to suppress the myc oncogenic pathway (miRNA data)

Project description:microRNA importance in the myc pathway in Burkitt lymphoma.

2012-04-09 | GSE29491 | GEO

Combinatorial effects of microRNA to suppress the myc oncogenic pathway

2012-03-30 | GSE23026 | GEO

Expression data from Burkitt lymphoma cases

Project description:Burkitt lymphoma is the commonest cancer in children in Africa. We compared the gene expression profiles of African Burkitt lymphoma patients with those of cases presented in Western countries in both immunocompetent (sporadic Burkitt lymphoma) and HIV-infected patients (immunodeficiency associated Burkitt lymphoma). We used microarrays to detail the global programme of gene expression in different subtypes of Burkitt lymphoma.

2011-01-20 | GSE26673 | GEO

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

Project description:The distinction between the Burkitt lymphoma and diffuse large B-cell lymphoma is imprecise using current diagnostic criteria. We applied transcriptional and genomic profiling to molecularly define Burkitt lymphoma. Gene expression profiling employing Affymetrix GeneChips (U133A) was performed in 220 mature aggressive B-cell lymphomas, including a core group of eight Burkitt lymphomas, which fulfilled all diagnostic criteria of the WHO classification. A molecular signature of Burkitt lymphoma was generated. Chromosomal abnormalities were detected by interphase fluorescence in-situ hybridization and array comparative genomic hybridization. The molecular Burkitt lymphoma signature identified 44 cases. Fifteen of these cases lacked a morphology typical for Burkitt/Burkitt-like lymphoma. The vast majority (88%) of the 176 lymphomas without the molecular Burkitt lymphoma signature represented diffuse large B-cell lymphomas. In 20% of these cases a MYC break was detectable which was associated with complex chromosomal changes. Our molecular definition of Burkitt lymphoma sharpens and extends the spectrum of Burkitt lymphoma. In mature aggressive B-cell lymphomas without a Burkitt lymphoma signature, a chromosomal break in the MYC locus proved to be associated with adverse clinical outcome. Keywords: Gene expression

2006-06-07 | GSE4475 | GEO

Transcription profiling of human Burkitts lymphomas

2008-06-13 | E-GEOD-4475 | biostudies-arrayexpress

Transcription profiling of Burkitt lymphoma cases

2011-01-20 | E-GEOD-26673 | biostudies-arrayexpress

Project description:Chidhood Burkitt Lymphoma

| PRJNA622666 | ENA